{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:18:33Z","timestamp":1790983113210,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["CHEST"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.chest.2026.02.012","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:18:35Z","timestamp":1786353515000},"page":"e47-e51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Reversible Intrapulmonary Vascular Dilatation in a Patient Treated With Luspatercept for Myelodysplastic Syndrome"],"prefix":"10.1016","volume":"170","author":[{"given":"Fatema","family":"Al Lawati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie E.","family":"Faughnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Granton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Climans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amar","family":"Thakrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1858-0387","authenticated-orcid":false,"given":"Genevi\u00e8ve C.","family":"Digby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.chest.2026.02.012_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.chest.2017.09.035","article-title":"Clinical impact of intrapulmonary vascular dilatation in candidates for liver transplant","volume":"153","author":"DuBrock","year":"2018","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.chest.2026.02.012_bib2","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/HEP.0000000000000605","article-title":"Physiologic changes in the hepatopulmonary syndrome before and after liver transplant: a longitudinal and predictor analysis","volume":"79","author":"Zhao","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.chest.2026.02.012_bib3","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1053\/j.gastro.2008.06.038","article-title":"Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates","volume":"135","author":"Fallon","year":"2008","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.chest.2026.02.012_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa1908892","article-title":"Luspatercept in patients with lower-risk myelodysplastic syndromes","volume":"382","author":"Fenaux","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.chest.2026.02.012_bib5","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2026.02.012_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1183\/09031936.00104309","article-title":"Graded contrast echocardiography in pulmonary arteriovenous malformations","volume":"35","author":"Parra","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.chest.2026.02.012_bib7","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMoa2213558","article-title":"Phase 3 trial of sotatercept for treatment of pulmonary arterial hypertension","volume":"388","author":"Hoeper","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.chest.2026.02.012_bib8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1164\/rccm.201912-2514LE","article-title":"BMP9\/10 in pulmonary vascular complications of liver disease","volume":"201","author":"Rochon","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2026.02.012_bib9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1164\/rccm.202307-1289OC","article-title":"Disrupted BMP-9 signaling impairs pulmonary vascular integrity in hepatopulmonary syndrome","volume":"210","author":"Robert","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2026.02.012_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102794","article-title":"Reduced circulating BMP9 and BMP10 and elevated endoglin are associated with disease severity, decompensation and pulmonary vascular syndromes in patients with cirrhosis","volume":"56","author":"Owen","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.chest.2026.02.012_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fgene.2014.00456","article-title":"Emerging roles of BMP9 and BMP10 in hereditary hemorrhagic telangiectasia","volume":"5","author":"Tillet","year":"2015","journal-title":"Front Genet"},{"issue":"5","key":"10.1016\/j.chest.2026.02.012_bib12","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1164\/rccm.202405-0895ED","article-title":"Hepatopulmonary syndrome, another face of dysregulated BMP9 signaling","volume":"210","author":"Sangam","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2026.02.012_bib13","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/cvr\/cvab187","article-title":"Different cardiovascular and pulmonary phenotypes for single- and double-knock-out mice deficient in BMP9 and BMP10","volume":"118","author":"Bouvard","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"7","key":"10.1016\/j.chest.2026.02.012_bib14","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1164\/rccm.202501-0056RL","article-title":"Development of new intrapulmonary shunts in pulmonary arterial hypertension patients treated with sotatercept","volume":"211","author":"Mitchell","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.chest.2026.02.012_bib15","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1164\/rccm.202502-0344RL","article-title":"Severe hypoxemia and pulmonary capillary dilatations in pulmonary arterial hypertension patients treated with sotatercept","volume":"211","author":"Olsson","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.chest.2026.02.012_bib16","unstructured":"Luspatercept (RX). Medscape drugs & diseases. Accessed April 22, 2025. Medscape website. https:\/\/reference.medscape.com\/drug\/reblozyl-luspatercept-1000359"}],"container-title":["CHEST"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369226002849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369226002849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:21:59Z","timestamp":1786353719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369226002849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0012369226002849"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2026.02.012","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversible Intrapulmonary Vascular Dilatation in a Patient Treated With Luspatercept for Myelodysplastic Syndrome","name":"articletitle","label":"Article Title"},{"value":"CHEST","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2026.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}